Salix Announces Issuance of U.S. Patent for Rifaximin

Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,452,857. This patent provides protection until August 2019.

The details can be read here.